BIAYA MEDIK LANGSUNG KEMOTERAPI PASIEN KANKER KOLOREKTAL RUANG PERAWATAN KELAS 3 PESERTA JKN RUMAH SAKIT “X” DI KOTA SEMARANG

Fransisca Tri Kurniawati; Fef Rukminingsih

doi:10.33759/jrki.v7i2.738

Authors

Fransisca Tri Kurniawati Politeknik Katolik Mangun Wijaya
Fef Rukminingsih Politeknik Katolik Mangun Wijaya

DOI:

https://doi.org/10.33759/jrki.v7i2.738

Keywords:

Direct medical cost, Colorectal cancer, Chemotherapy

Abstract

Colorectal cancer (CRC) is the second most common cancer in men after lung cancer. The cost of CRC therapy is very high. The National Health Insurance (NHI) through BPJS covers the direct medical costs of CRC patients. One of the therapies for CRC patients is chemotherapy. Based on its level, chemotherapy is classified into mild, moderate and severe chemotherapy. This study aims to determine the average direct medical costs of mild chemotherapy in CRC patients in class 3 treatment rooms at “X” Hospital in Semarang City. This study is a descriptive observational study, using retrospective data. Data were obtained from medical records (MR) and billing data for CRC patients participating in NHI who underwent mild chemotherapy (C-4-13-I) for the period January–June 2023. The inclusion criteria were CRC patients with ICD code Z5.1.1, aged 18-65 years, class 3 treatment rooms. Patients who upgrade their class treatment rooms are excluded. Data processing was carried out by calculating the average direct medical costs based on patient billing. The results of the study obtained 79 chemotherapy billing data for CRC patients. Most patients were >45 years old, namely 69 patients (87.34%), male as many as 63 patients (79.75%). The most common chemotherapy regimens were FOLFIRI (59.49%) and FOLFOX (34.18%). The average length of treatment was 4.3 days. The largest direct medical cost components were medical and health personnel costs (45.17%) and drug costs (37.22%). The average direct medical cost for mild chemotherapy in class 3 treatment rooms was IDR 2,490,615.

Downloads

Download data is not yet available.

References

Agiwahyuanto, F., Widianawati, E., Wulan, W., & Putri, R. (2020). Tarif Rumah Sakit dengan Tarif INA-CBGs Pasien Rawat Inap. HIGEIA (Journal of Public Health Research and Development). HIGEIA (Journal of Public Health Research and Development), 4(4), 520–532.

Amalia, A. R. (2021). Analisis Biaya Riil dan Kesesuaian dengan Tarif INA-CBG’S Pada Pasien Kanker Kolorektal Di RSUD Dr. Moewardi Surakarta Tahun 2018. Jurnal Farmasi Indonesia, 18(2), 121–132. https://doi.org/10.31001/jfi.v18i2.823

Ashariati, A. (2019). Manajemen Kanker Payudara Komprehensif (A. Ashariati, M. P. Sedana, U. Y. Bintoro, M. N. Diansyah, P. N. A. Amrita, M. Savitri, P. Z. Romadhon, & A. Permatasari, Eds.).

Kemenkes RI. (2018). Panduan Penatalaksanaan Kanker Kolorektal (Vol. 1). Kementerian Kesehatan Republik Indonesia.

Kemenkes RI. (2023). Standar Tarif Pelayanan Kesehatan Dalam Penyelenggaraan Program Jaminan Kesehatan. Kementerian Kesehatan Republik Indonesia.

Khalil, K., Musallam, H., Hassan, M., & Mahmoud, I. (2022). Triplet (FOLFOXIRI) Versus Doublet (FOLFOX or FOLFIRI) Regimen as First Line Treatment in Metastatic Colorectal Carcinoma, a Prospective Phase II, Randomized Controlled Trial. Asian Pacific Journal of Cancer Prevention, 23(10), 3421–3429. https://doi.org/10.31557/APJCP.2022.23.10.3421

Khosama, Y. (2015). Faktor Risiko Kanker Kolorektal.Fakultas Kedokteran Universitas Sam Ratulangi. CDK-234, 42(11), 829–832.

Lin, J. H., Zhang, S. M., Rexrode, K. M., Manson, J. E., Chan, A. T., Wu, K., Tworoger, S. S., Hankinson, S. E., Fuchs, C., Gaziano, J. M., Buring, J. E., & Giovannucci, E. (2013). Association Between Sex Hormones and Colorectal Cancer Risk in Men and Women. Clinical Gastroenterology and Hepatology, 11(4), 419-424.e1. https://doi.org/10.1016/j.cgh.2012.11.012

Miftahussurur, M., Aji Savitri, C. M., Ayu Rezkhita, Y. A., Vidyani, A., Doohan, D., Priyantini, D., Sugihartono, T., & Yamaoka, Y. (2023). A Systematic Review of Complementary Therapies in Colorectal cancer patients: Summarizing the Current Global Options. Research Journal of Pharmacy and Technology, 1540–1546. https://doi.org/10.52711/0974-360X.2023.00252

Mulyandarini, H., Rahman, N., Adelina, R. (2022). Studi Literatur Serat, Kalsium, dan MirNa Pada Penyakit Kanker Kolorektal (Vol. 2, Issue 2). http://journal.binawan.ac.id/JAKAGI

Pebrianty. (2016). Umur, Komorbidits, dan Metastasis Dalam Penentuan Kondisi Psien Kanker Kolorektal di Kota Makassar (Aged, Comorbidity, and Metastatic as Determine of Colorectal Cancer Patient’s Condition in Makassar City). Jurnal IKESMA, 12(1).

Sri Rahayu, M., Sayuti, M., & Raihan, M. (2023). Hubungan Antara Faktor Usia dan Jenis Kelamin dengan Kejadian Kanker Kolorektal di Rumah Sakit Umum Cut Meutia Pada Tahun 2020. Jurnal Ilmiah Manusia Dan Kesehatan, 6(1), 78–87. https://doi.org/10.31850/makes.v6i1.1949

Sunakawa, Y., Schirripa, M., & Lenz, H.-J. (2016). Understanding the FOLFOXIRI-regimen to optimize treatment for metastatic colorectal cancer. Critical Reviews in Oncology/Hematology, 100, 117–126. https://doi.org/10.1016/j.critrevonc.2016.01.020

Widya Astuti, G. A. E., Siswandi, A., Wulandari, M., & Kumala, I. (2023). Karakteristik Pasien Kanker Kolorektal Stadium I-IV Di Rumah Sakit Umum Daerah Dr. H. Abdul Moeloek. Jurnal Ilmu Kedokteran Dan Kesehatan, 10(7), 2360–2374. https://doi.org/10.33024/jikk.v10i7.10805

Wintariani, N. P., Suwantara, I. P. T., & Suena, N. M. D. S. (2017). ANALISIS KESESUAIAN BIAYA RIIL PASIEN KEMOTERAPI KANKER SERVIKS DENGAN TARIF INA-CBG’s PADA PASIEN JKN RAWAT INAP DI RSUP SANGLAH DENPASAR TAHUN 2014. Jurnal Ilmiah Medicamento, 3(1). https://doi.org/10.36733/medicamento.v3i1.1053

Wiratama, I. N. A., Djatmiko, W., Ardiansyah, I. R., Salipi, M. B., Ilmi, A. F. N., & Maharani, N. (2018). Comparative study: Side effects of Folfox4 and folfiri for colorectal cancer chemotherapy regiment in Margono Soekarjo Hospital, Purwokerto. Annals of Oncology, 29, ix31–ix32. https://doi.org/10.1093/annonc/mdy431.013

World Health Organization. (2022). International Agency for Research on Cancer. In The Global Cancer Observatory (pp. 1–2).

Yuli Atmojo, C., Elasari, Y., Adi Nugroho, T., Studi, P. S., Kesehatan, F., Aisyah Pringsewu, U., Lampung, B., Studi, P. D., & Medis, R. (2024). Journal of Nursing Invention FAKTOR-FAKTOR YANG BERHUBUNGAN DENGAN LAMA HARI RAWAT PASIEN BPJS KESEHATAN DI RUMAH SAKIT MARDI WALUYO KOTA METRO. https://doi.org/10.33859/jni